Barrington Research reaffirmed their outperform rating on shares of Stericycle Inc. (NASDAQ:SRCL) in a report issued on Wednesday. The firm currently has a $88.00 price target on the stock, down from their prior price target of $100.00.
SRCL has been the topic of a number of other research reports. Royal Bank Of Canada dropped their target price on Stericycle from $89.00 to $77.00 and set an underperform rating on the stock in a report on Monday, September 19th. Jefferies Group reaffirmed a buy rating and set a $125.00 price objective on shares of Stericycle in a report on Tuesday, August 23rd. Zacks Investment Research raised Stericycle from a strong sell rating to a hold rating in a report on Wednesday, September 28th. Imperial Capital dropped their price objective on Stericycle from $93.50 to $80.00 and set an underperform rating on the stock in a report on Friday, September 9th. Finally, Macquarie assumed coverage on Stericycle in a report on Thursday, August 25th. They set a neutral rating and a $96.00 price objective on the stock. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company’s stock. The stock has an average rating of Hold and an average price target of $103.54.
Stericycle (NASDAQ:SRCL) last released its earnings results on Thursday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $1.18. The business had revenue of $891.60 million for the quarter, compared to analyst estimates of $910.29 million. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. The company’s revenue for the quarter was up 24.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 earnings per share.
In other news, Director Rodney F. Dammeyer sold 10,188 shares of the company’s stock in a transaction on Wednesday, August 17th. The stock was sold at an average price of $85.50, for a total value of $871,074.00. Following the sale, the director now directly owns 10,188 shares in the company, valued at $871,074. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP John P. Schetz sold 1,398 shares of the company’s stock in a transaction on Wednesday, September 14th. The shares were sold at an average price of $81.85, for a total value of $114,426.30. Following the completion of the sale, the executive vice president now owns 1,088 shares in the company, valued at $89,052.80. The disclosure for this sale can be found here. 3.30% of the stock is owned by insiders.
Several hedge funds have recently modified their holdings of the stock. Balentine LLC increased its stake in shares of Stericycle by 34.9% in the first quarter. Balentine LLC now owns 1,064 shares of the company’s stock valued at $134,000 after buying an additional 275 shares in the last quarter. Pinkerton Retirement Specialists LLC bought a new stake in shares of Stericycle during the second quarter valued at about $131,000. Canada Pension Plan Investment Board increased its stake in shares of Stericycle by 54.1% in the first quarter. Canada Pension Plan Investment Board now owns 1,415 shares of the company’s stock valued at $179,000 after buying an additional 497 shares in the last quarter. Parkside Financial Bank & Trust increased its stake in shares of Stericycle by 2.9% in the second quarter. Parkside Financial Bank & Trust now owns 1,432 shares of the company’s stock valued at $149,000 after buying an additional 41 shares in the last quarter. Finally, Meeder Asset Management Inc. bought a new stake in shares of Stericycle during the second quarter valued at about $155,000. Institutional investors and hedge funds own 92.72% of the company’s stock.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.